Skip to content

Clinical trials

Phase 1/2 Prostatic Hyperplasia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Hyperplasia Phase: Phase 1/2 Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20091
20111
20131
20151
20161
20191
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Allergan1
American Medical Systems1
Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation1
James B. Spies, MD1
QLT Inc.1
Resurge Therapeutics Inc.1
Rhode Island Hospital1
Sophiris Bio Corp1
Taipei Veterans General Hospital, Taiwan1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Hyperplasia9
Lower Urinary Tract Symptoms2
Prostatic Diseases1
Prostatitis1
Urinary Bladder Neck Obstruction1

Trials

Showing 26 to 9 of 9. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.